MYDECINE HEALTH SCIENCES
LIVE

Serial Number

97267542

Owner

Mydecine Innovations Group Inc

Attorney

Tyler K. Berger

First Use Date

Apr 1, 2020

Filing Date

Feb 15, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MYDECINE HEALTH SCIENCES Trademark

Serial Number: 97267542 • Registration: 7010501

MYDECINE HEALTH SCIENCES is a trademark filed by Mydecine Innovations Group Inc on February 15, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Mydecine Innovations Group Inc (10 trademarks)

Lower Level Suite A
Denver, CO 80231

Entity Type: 03

Trademark Details

Filing Date

February 15, 2022

Registration Date

March 28, 2023

First Use Anywhere

April 1, 2020

First Use in Commerce

April 1, 2020

Published for Opposition

January 10, 2023

Goods & Services

Addiction treatment services; Advisory services relating to health care; Advisory services relating to health; Alternative medicine services; Clinical mental health counseling services; Consultancy services relating to health care; Drug use testing services; Health care; Health care consulting in the field of mental health; Health care services for treating mental illnesses; Health care services, namely, providing a database in the field of mental health information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Health care services, namely, providing a database in the field of mycology information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Health care services, namely, pharmaceutical drug development services, medical research, biological research, product research and development and pharmaceutical research services; Health clinic services; Managed health care services; Medical services; Mental health services; Mental health therapy services; Providing mental health and wellness information; Psychotherapy; Psychotherapy services

Biological research; Biological research and analysis; Biomedical research services; Chemical, biochemical, biological and bacteriological research and analysis; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of pharmacogenetics; Consulting services in the field of biotechnology; Development of pharmaceutical preparations and medicines; Genetic testing for scientific research purposes; Laboratory research in the field of mental health; Laboratory research in the field of mycology; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of mental health; Medical and scientific research in the field of mycology; Medical and scientific research, namely, conducting clinical trials for others; Medical laboratory services; Medical research; Medical research services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Product research and development; Providing information about medical research; Providing information about medical research in the field of mental health; Providing information about medical research in the field of mycology; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Quality control for others; Research and development in the field of mental health; Research and development in the field of mycology; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of technology in the field of mental health; Research and development of technology in the field of mycology; Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific and technological services, namely, research and design in the field of mental health; Scientific and technological services, namely, research and design in the field of mycology; Scientific and technological services, namely, scientific research, analysis, testing in the field of medical information, medical diagnostics, healthcare, computer technology, public health, and public health research in the field of mental health; Scientific and technological services, namely, scientific research, analysis, testing in the field of medical information, medical diagnostics, healthcare, computer technology, public health, and public health research in the field of mycology; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research and development; Scientific research in the field of genetics and genetic engineering; Testing of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others in the field of mental health; Scientific research in the nature of conducting clinical trials for others in the field of mycology

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 28, 2023 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 7, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 7, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 7, 2023 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 3, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 3, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 3, 2023 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 10, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 10, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 21, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 5, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 5, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 5, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 5, 2022 CNEA
ASSIGNED TO EXAMINER
Nov 30, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 25, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 25, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 25, 2022 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 18, 2022 NWOS
NEW APPLICATION ENTERED
Feb 18, 2022 NWAP